← Every company
Ascendis Pharma A/S SEC Filings
What Ascendis Pharma A/S has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ASND overview →Filings on file
10
since Mar 22, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Feb 11, 2026 | Annual report 20-F | Read ↗ |
| Feb 12, 2025 | Annual report 20-F | Read ↗ |
| Feb 7, 2024 | Annual report 20-F | Read ↗ |
| Feb 16, 2023 | Annual report 20-F | Read ↗ |
| Mar 2, 2022 | Annual report 20-F | Read ↗ |
| Mar 10, 2021 | Annual report 20-F | Read ↗ |
| Apr 3, 2020 | Annual report 20-F | Read ↗ |
| Apr 3, 2019 | Annual report 20-F | Read ↗ |
| Mar 28, 2018 | Annual report 20-F | Read ↗ |
| Mar 22, 2017 | Annual report 20-F | Read ↗ |
Source: Ascendis Pharma A/S's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ASND
Company overviewEverything on ASND in one place, with the price.Insider tradingWhat ASND's own officers and directors buy and sell.LobbyingWhat ASND spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ASND's account, and who they worked for.Federal contractsWhat federal agencies pay ASND.PatentsWhat ASND is filing at the patent office.